Synthesis and biological activity of 1α,25-dihydroxy-18-norvitamin D3 and 1α,25-dihydroxy-18,19-dinorvitamin D3

Journal of Medicinal Chemistry

Volumn 39, Issue 22, 1996, Pages 4497-4506

  Sicinski, Rafal R ^a,b   Perlman, Kato L ^a   Prahl, Jean ^a   Smith, Connie ^a   DeLuca, Hector F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

1ALPHA,25 DIHYDROXY 18 NORVITAMIN D3; 1ALPHA,25 DIHYDROXY 18,19 DINORVITAMIN D3; CALCITRIOL DERIVATIVE; UNCLASSIFIED DRUG; VITAMIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MINERAL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL PROLIFERATION; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; MALE; NONHUMAN; RAT;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; BONE AND BONES; CALCITRIOL; CALCIUM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; HL-60 CELLS; HUMANS; INTESTINES; MALE; RATS; RATS, SPRAGUE-DAWLEY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029973195     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950745t     Document Type: Article

References (63)

1. Kodicek, E. The story of vitamin D, from vitamin to hormone. Lancet 1974, 1, 325-329.
2. DeLuca, H. F. Vitamin D: The vitamin and the hormone. Fed. Proc. 1974, 33, 2211-2219.
3. (a) Reichel, H.; Koeffler, H. P.; Norman, A. W. The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 1989, 320, 980-991.
4. (b) DeLuca, H. F. The vitamin D story: A collaborative effort of basic science and clinical medicine. FASEB J. 1988, 2, 224-236.
5. 3 and its physiological implications. Steroids 1987, 49, 29-53.
6. (d) Ikekawa, N. Structures and biological activities of vitamin D metabolites and their analogs. Med. Res. Rev. 1987, 7, 333-366.
7. (e) DeLuca, H. F.; Schnoes, H. K. Vitamin D: Metabolism and mechanism of action. Annu. Rep. Med. Chem. 1984, 19, 179-190.
8. 3 in the myeloid cell differentiation. Proc. Soc. Exp. Biol. Med. 1989, 191, 214-220.
9. (b) Ostrem, V. K.; Lau, W. F.; Lee, S. H.; Perlman, K.; Prahl, J.; Schnoes, H. K.; DeLuca, H. F.; Ikekawa, N. Induction of monocytic differentiation of HL-60 cells by 1,25-dihydroxyvitamin D analogs. J. Biol. Chem. 1987, 262, 14164-14171.
10. (c) MacLaughlin, J. A.; Gange, W.; Taylor, D.; Smith, E.; Holick, M. F. Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 5409-5412.
11. 3: a novel immunoregulatory hormone. Science (Washington, D.C.) 1984, 224, 1438-1440.
12. 3 induces differentiation of human myeloid leukemia cells. Biochem. Biophys. Res. Commun. 1981, 102, 937-943.
13. (a) Perlman, K. L.; Swenson, R. E.; Paaren, H. E.; Schnoes, H. K.; DeLuca, H. F. Novel synthesis of 19-nor-vitamin D compounds. Tetrahedron Lett. 1991, 32, 7663-7666.
14. 3, a novel synthetic vitamin D-related compound with potential therapeutic activity. Tetrahedron Lett. 1990, 31, 1823-1824.
15. 3 and related analogues. J. Org. Chem. 1992, 57, 3214-3217.
16. 3. Tetrahedron Lett. 1992, 33, 1503-1506.
17. 3. BioMed. Chem. Lett. 1993, 3, 1855-1858.
18. (a) Lythgoe, B. Synthetic approaches to vitamin D and its relatives. Chem. Soc. Rev. 1981, 449-475.
19. 3. J. Chem. Soc., Perkin Trans. 1 1978, 590-595.
20. (c) Lythgoe, B.; Moran, T. A.; Nambudiry, M. E. N.; Ruston, S. Allylic phosphine oxides as precursors of conjugated dienes of defined geometry. J. Chem. Soc., Perkin Trans 1 1976, 2386-2390.
21. (a) Baggiolini, E. G.; Iacobelli, J. A.; Hennessy, B. M.; Batcho, A. D.; Sereno, J. F.; Uskokovic, M. R. Stereocontrolled total synthesis of 1α,25-dihydroxycholecalciferol and 1α,25-dihydroxyergocalciferol. J. Org. Chem. 1986, 51, 3098-3108.
22. (b) Baggiolini, E. G.; Iacobelli, J. A.; Hennessy, B. M.; Uskokovic, M. R. Stereoselective total synthesis of 1α,25-dihydroxycholecalciferol. J. Am. Chem. Soc. 1982, 104, 2945-2948.
23. (a) Maestro, M. A.; Sardina, F. J.; Castedo, L.; Mourino, A. Stereoselective synthesis and thermal rearrangement of the first analogue of (7Z)-vitamin D. J. Org. Chem. 1991, 56, 3582-3587.
24. (b) Peterson, P. E.; Leffew, R. L. B.; Jensen, B. L. Studies of the ketone obtained from the ozonolysis of vitamin D. Molecular mechanics calculations for it and related hydrindanones. J. Org. Chem. 1986, 51, 1948-1954.
25. 3. Chem. Ber. 1957, 90, 664-673.
26. 3. Application of the low-valent titanium-induced reductive elimination. J. Org. Chem. 1987, 52, 3560-3566.
27. Heusler, K.; Kalvoda, J. Selective functionalization of angular methyl group and further transformation to 19-norsteroids. In Rodd's Chemistry of carbon compounds, Vol. II, Acyclic compounds, part D - Steroids, 2nd ed.; Coffey, S., Eds.; Elsevier Publishing Co.: Amsterdam, 1970; pp 237-287.
28. s) were carried out using the algorithm from the MM+ HyperChem (release 4.0) software package (Autodesk, Inc., 1994). MM+ is an all-atom force field based on the MM2 functional form.
29. (a) Akhtar, M.; Barton, D. H. R. Reactions at positions 19 in the steroid nucleus. A convenient synthesis of 19-norsteroids. J. Am. Chem. Soc. 1964, 86, 1528-1536.
30. (b) Akhtar, M.; Pechet, M. M. The mechanism of the Barton's reaction. J. Am. Chem. Soc. 1964, 86, 265-268.
31. (c) Barton, D. H. R.; Beaton, J. M.; Geller, L. E.; Pechet, M. M. A new photochemical reaction. J. Am. Chem. Soc. 1961, 83, 4076-4083.
32. (a) Doyle, M. P.; Terpstra, J. W.; Pickering, R. A.; LePoire, D. M. Hydrolysis, nitrosyl exchange, and synthesis of alkyl nitrites. J. Org. Chem. 1983, 48, 3379-3382.
33. (b) Glover, S. A.; Goosen, A.; McCleland, C. W.; Vogel, F. R. Alcoholysis of t-butyl nitrite. Synthesis of alkyl nitrites. S. Afr. J. Chem. 1981, 34, 96-100.
34. Karabatsos, G. J.; Taller, R. A. Structural studies by nuclear magnetic resonance-XV. Conformations and configurations of oximes. Tetrahedron 1968, 24, 3347-3360.
35. (a) Jen, T.; Wolff, M. E. C-19 functionalized steroids. V. Synthesis of estrogen biosynthesis intermediates. J. Org. Chem. 1963, 28, 1573-1575.
36. (b) Ambrose, D.; Brady, O. L. The isomerism of the oximes. Part XLIII. The kinetics of the pyrolysis of acyl derivatives. J. Chem. Soc. 1950, 1243-1249.
37. (a) Debal, A.; Cuvigny, T.; Larcheveque, M. Activation by a cyano group: II; a new synthesis of substituted primary alcohols. Synthesis 1976, 391-393.
38. (b) Cuvigny, T.; Larcheveque, M.; Normant, H. Decyanuration des nitrites par les métaux alcalins en milieu HMPT. Bull. Soc. Chim. Fr. 1974, 1174-1178.
39. Ohsawa, T.; Kobayashi, T.; Mizuguchi, Y.; Saitoh, T.; Oishi, T. Dissolving metal reduction with crown ether - reductive decyanation. Tetrahedron Lett. 1985, 26, 6103-6106.
40. (a) Savoia, D.; Tagliavini, E.; Trombini, C.; Umani-Ronchi, A. Potassium on alumina as a reagent for reductive decyanation of alkylnitrites. J. Org. Chem. 1980, 45, 3227-3229.
41. (b) van Tamelen, E. E.; Rudler, H.; Bjorklund, C. Transition metal promoted reductive decyanation of alkyl nitriles. J. Am. Chem. Soc. 1971, 93, 7113-7114.
42. (c) Arapakos, P. G.; Scott, M. K.; Huber, F. E., Jr. The reaction of nitriles with solvated electrons. III. J. Am. Chem. Soc. 1969, 91, 2059-2062.
43. 5(6)-steroidi mediante dissoluzione di metalli alcalini. Gazz. Chim. Ital. 1963, 93, 525-541.
44. Deshayes, H.; Pete, J. P. Reduction of alkyl esters to alkanes by sodium in hexamethylphosphoric triamide. A new method for the deoxygenation of alcohols. J. Chem. Soc. Chem. Commun. 1978, 567-568.
45. (a) Fall, Y.; Torneiro, M.; Castedo, L.; Mourino, A. A nitrile approach to the synthesis of the side chain of vitamin D metabolites and analogues. Tetrahedron Lett. 1992, 33, 6683-6686.
46. 3 functionalized at C-11. Tetrahedron Lett. 1992, 33, 105-108.
47. Kirk, D. N. The chiroptical properties of carbonyl compounds. Tetrahedron 1986, 42, 777-818.
48. Kirk, D. N. Chiroptical studies. Part 96. Short wavelength (190 nm) circular dichroism of ketones. J. Chem. Soc., Perkin Trans. 1 1980, 787-803.
49. Kirk, D. N.; Klyne, W. Optical rotatory dispersion and circular dichroism. Part LXXXII. An empirical analysis of the circular dichroism of decalones and their analogues. J. Chem. Soc., Perkin Trans. 1 1974, 1076-1103.
50. (a) Duddeck, H.; Frelek, J.; Krüger, C.; Snatzke, G.; Szczepek, W. J.; Wagner, P.; Werner, S. Spectroscopic properties of 6-hydroximino-5β-cholestane derivatives. Tetrahedron: Asymmetry 1992, 3, 613-620.
51. (b) Snatzke, G.; Frelek, J.; Szczepek, W. J. Circular dichroism of some steroidal 6-membered ketoximes. Tetrahedron: Asymmetry 1990, 1, 649-659 and references cited therein.
52. 3 to its 1,25-dihydroxy metabolite. Tetrahedron Lett. 1991, 32, 6057-6060.
53. 3. BioMed. Chem. Lett. 1995, 5, 159-162.
54. 3 analogue. Structure determination of tertiary alcohols by carbon-13 nuclear magnetic resonance spectroscopy. J. Org. Chem. 1979, 44, 3077-3080.
55. (a) Havinga, E. Vitamin D, example and challenge. Experientia 1973, 29, 1181-1193.
56. (b) Sanders, G. M.; Pot, J.; Havinga, E. Some recent results in the chemistry and stereochemistry of vitamin D and its isomers. Fortschr. Chem. Org. Naturst. 1969, 27, 129-157.
57. (c) Pot, J. Synthese en eigenschappen van enige 13α-steroiden en 13α-precalciferol analoga. Ph.D. Thesis, State University of Leiden, The Netherlands, 1964.
58. 3. J. Org. Chem. 1984, 49, 2152-2158.
59. 3. J. Med. Chem. 1994, 37, 3730-3738.
60. Suda, T.; DeLuca, H. F.; Tanaka, Y. Biological activity of 25-hydroxyergocalciferol in rats. J. Nutr. 1970, 100, 1049-1052.
61. Uhland-Smith, A.; DeLuca, H. F. 1,25-Dihydroxycholecalciferol analogs cannot replace vitamin D in normocalcemic male rats. J. Nutr. 1993, 123, 1777-1785.
62. Snedecor, G. W.; Cochran, W. G. Statistical Methods, 6th ed.; Iowa State University Prees: Ames, IA, 1967.
63. 3: Interaction with distinct receptor domains. Biochemistry 1986, 25, 4523-4534.